Reflux| Volume 101, P63-66, March 2017

Delayed Obstruction With Asymptomatic Loss of Renal Function After Dextranomer/Hyaluronic Acid Copolymer (Deflux) Injection for Vesicoureteral Reflux: A Close Look at a Disturbing Outcome

Published:September 26, 2016DOI:
      Dextranomer/hyaluronic acid copolymer (Deflux) first received Food and Drug Administration approval in 2001 for endoscopic injection in children with grade II-IV vesicoureteral reflux VUR. As experience has grown, Deflux has been used more liberally with encouraging results. We report 3 cases where Deflux was used in off-label fashion, resulting in delayed ureteral obstruction and loss of renal function (range 18-52 months postoperatively). We now place increased emphasis on the need for long-term follow-up after Deflux in both routine and complex cases, particularly in situations of off-label use.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Stenberg A.
        • Lackgren G.
        A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and short-term clinical results.
        J Urol. 1995; 154: 800-803
        • Routh J.C.
        • Inman B.A.
        • Reinberg Y.
        Dextranomer/hyaluronic acid for pediatric vesicoureteral reflux: systematic review.
        Pediatrics. 2010; 125: 1010-1019
        • Bajpai M.
        • Verma A.
        • Panda S.S.
        Endoscopic treatment of vesico-ureteral reflux: experience of 99 ureteric moieties.
        J Indian Assoc Pediatr Surg. 2013; 18: 133
        • Kirsch A.J.
        • Arlen A.M.
        Evaluation of new Deflux administration techniques: intraureteric HIT and double HIT for the endoscopic correction of vesicoureteral reflux.
        Expert Rev Med Devices. 2014; 11: 439-446
        • Snodgrass W.T.
        Obstruction of a dysmorphic ureter following dextranomer/hyaluronic acid copolymer.
        J Urol. 2004; 171: 395-396
        • Vandersteen D.R.
        • Routh J.C.
        • Kirsch A.J.
        • et al.
        Postoperative ureteral obstruction after subureteral injection of dextranomer/hyaluronic acid copolymer.
        J Urol. 2006; 176: 1593-1595
        • Rubenwolf P.C.
        • Ebert A.
        • Ruemmele P.
        • Rösch W.H.
        Delayed-onset ureteral obstruction after endoscopic dextranomer/hyaluronic acid copolymer (Deflux) injection for treatment of vesicoureteral reflux in children: a case series.
        Urology. 2013; 81: 659-662
        • Abbo O.
        • Bouali O.
        • Beauval J.B.
        • Moscovici J.
        • Galinier P.
        Distal and late ureteral obstruction: a rare complication following dextranomer/hyaluronic acid injection for vesicoureteral reflux in children.
        Prog Urol. 2012; 22: 192-194
        • Salix Pharmaceuticals, Inc.
        (Available at:) (Updated)
        • Kim H.
        • Kim B.S.
        • Cheong H.I.
        • Cho B.S.
        • Kim K.M.
        Long-term results of endoscopic Deflux® injection for vesicoureteral reflux in children.
        Child Kidney Dis. 2015; 19: 31-38
        • Kirsch A.J.
        • Perez-Brayfield M.
        • Smith E.A.
        • Scherz H.C.
        The modified sting procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter.
        J Urol. 2004; 171: 2413-2416
        • Bayibov R.
        • Sizonok V.
        • Sergey B.
        • et al.
        Do the type of bulking agents and injection method have any influence on the incidence of ureteral obstruction by endoscopic treatment of reflux?.
        J Pediatr Urol. 2015;
        • Capozza N.
        • Lais A.
        • Matarazzo E.
        • Nappo S.
        • Patricolo M.
        • Caione P.
        Influence of voiding dysfunction on the outcome of endoscopic treatment for vesicoureteral reflux.
        J Urol. 2002; 168: 1695-1698
        • Baybikov R.
        • Sizonov V.
        • Bondarenko S.
        • et al.
        Treatment of ureteral obstruction after endoscopic injection in vesicoureteral reflux.
        J Pediatr Urol. 2015;
        • Nseyo U.
        • Mancini J.G.
        • Wiener J.S.
        Symptomatic bilateral delayed partial ureteral obstruction after bilateral endoscopic correction of vesicoureteral reflux with dextranomer/hyaluronic acid polymer.
        Urology. 2013; 81: 184-187